Sickle cell disease is the most common genetic disease in the world. Currently, there are approximately 250 million people worldwide who carry the gene responsible for sickle cell disease and other hemoglobin diseases. There are approximately 90,000 individuals diagnosed with sickle cell disease. Sickle cell is prominent in both African American and Hispanic populations. This seminar will discuss the rapid development of new gene therapy and the need for access to novel curative modalities for sickle cell disease.

ACCREDITATION STATEMENT: City of Hope is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

CREDIT DESIGNATION: City of Hope designates this live activity for a maximum of 3.25 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The following credit type(s) are being offered for this course:

  • AMA PRA Category 1  (3.25)

The following may apply AMA PRA Category 1 Credits for license renewal:

Registered Nurses: Nurses may report up to 3.25 credit hours toward the continuing education requirements for license renewal by their state Board of Registered Nurses (BRN). AMA PRA Category 1 Credits may be noted on the license renewal application in lieu of a BRN provider number.

Physician Assistants: The National Commission on Certification of Physicians Assistants states that AMA PRA Category 1 Credit accredited courses are acceptable for CME requirements for recertification.

Register Here

(0) comments

Welcome to the discussion.

Keep it Clean. Please avoid obscene, vulgar, lewd, racist or sexually-oriented language.
Don't Threaten. Threats of harming another person will not be tolerated.
Be Truthful. Don't knowingly lie about anyone or anything.
Be Nice. No racism, sexism or any sort of -ism that is degrading to another person.
Be Proactive. Use the 'Report' link on each comment to let us know of abusive posts.
Share with Us. We'd love to hear eyewitness accounts, the history behind an article.